SARS CoV2 permissive colon cancer cell line DLD1 validated for Spike protein binding and SARS CoV 2 pseudovirion assay
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.